Precigen to present at the 2021 wells fargo virtual healthcare conference and the h.c. wainwright 23rd annual global investment conference

Germantown, md., sept. 1, 2021 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced helen sabzevari, phd, president and ceo of precigen, will participate in two upcoming conferences.
PGEN Ratings Summary
PGEN Quant Ranking